Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Sell
360,443
-2,982
-0.8% -$133K 0.33% 76
2026
Q1
$17.5M Sell
363,425
-56,579
-13% -$2.64M 0.43% 61
2025
Q4
$20.4M Buy
420,004
+33,470
+9% +$1.66M 0.55% 55
2025
Q3
$18.2M Buy
+386,534
New +$18.7M 0.51% 57

Other funds holding SNY

CSM Advisors's SNY Position: Q2 2026 in Review

CSM Advisors reduced its Sanofi (SNY) stake by 0.82% in Q2 2026, selling an estimated $133K and leaving 360,443 shares worth $15.4M. The position accounts for 0.33% of the portfolio, ranked #76.

CSM Advisors first reported a position in SNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $20.4M in Q4 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • CSM Advisors held 360,443 shares of Sanofi worth $15.4M as of Q2 2026.
  • CSM Advisors sold 2,982 Sanofi shares in Q2 2026, an estimated $133K.
  • Sanofi made up 0.33% of CSM Advisors's portfolio in Q2 2026, its #76 holding.
  • CSM Advisors first reported a position in Sanofi in Q3 2025 and has held it in 4 quarters since.
  • CSM Advisors's Sanofi position peaked at $20.4M in Q4 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.